Antiretroviral Therapy Adherence Among Transgender Women Living With HIV

Jae M. Sevelius, Adam Carrico, Mallory O. Johnson

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Despite disproportionate rates of HIV among transgender women and evidence that medication adherence is necessary for treatment success and increased likelihood of survival, there has been little investigation into antiretroviral therapy (ART) adherence issues among transgender women. This study examined rates of self-reported ART adherence among transgender women on ART (n = 35) and well-established correlates of nonadherence, including depression, adherence self-efficacy, patient perceptions of interactions with their providers, and perceived adverse side effects of ART compared to other respondents (n = 2,770). Transgender women on ART were less likely to report 90% adherence rates or higher and reported less confidence in their abilities to integrate treatment regimens into their daily lives. When transgender women were compared to other respondents, regardless of the current medication regimen, they reported significantly fewer positive interactions with their health care providers. Training for providers and integration of hormone therapy into HIV care is recommended.

Original languageEnglish (US)
Pages (from-to)256-264
Number of pages9
JournalJournal of the Association of Nurses in AIDS Care
Volume21
Issue number3
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Transgender Persons
HIV
Therapeutics
Aptitude
Medication Adherence
Self Efficacy
Health Personnel
Hormones
Depression
Survival

Keywords

  • adherence
  • AIDS
  • antiretroviral therapy
  • HIV
  • transgender
  • women

ASJC Scopus subject areas

  • Advanced and Specialized Nursing

Cite this

Antiretroviral Therapy Adherence Among Transgender Women Living With HIV. / Sevelius, Jae M.; Carrico, Adam; Johnson, Mallory O.

In: Journal of the Association of Nurses in AIDS Care, Vol. 21, No. 3, 01.05.2010, p. 256-264.

Research output: Contribution to journalArticle

@article{b6e4121b61c44a379f79a9dadb925113,
title = "Antiretroviral Therapy Adherence Among Transgender Women Living With HIV",
abstract = "Despite disproportionate rates of HIV among transgender women and evidence that medication adherence is necessary for treatment success and increased likelihood of survival, there has been little investigation into antiretroviral therapy (ART) adherence issues among transgender women. This study examined rates of self-reported ART adherence among transgender women on ART (n = 35) and well-established correlates of nonadherence, including depression, adherence self-efficacy, patient perceptions of interactions with their providers, and perceived adverse side effects of ART compared to other respondents (n = 2,770). Transgender women on ART were less likely to report 90{\%} adherence rates or higher and reported less confidence in their abilities to integrate treatment regimens into their daily lives. When transgender women were compared to other respondents, regardless of the current medication regimen, they reported significantly fewer positive interactions with their health care providers. Training for providers and integration of hormone therapy into HIV care is recommended.",
keywords = "adherence, AIDS, antiretroviral therapy, HIV, transgender, women",
author = "Sevelius, {Jae M.} and Adam Carrico and Johnson, {Mallory O.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.jana.2010.01.005",
language = "English (US)",
volume = "21",
pages = "256--264",
journal = "Journal of the Association of Nurses in AIDS Care",
issn = "1055-3290",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Antiretroviral Therapy Adherence Among Transgender Women Living With HIV

AU - Sevelius, Jae M.

AU - Carrico, Adam

AU - Johnson, Mallory O.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Despite disproportionate rates of HIV among transgender women and evidence that medication adherence is necessary for treatment success and increased likelihood of survival, there has been little investigation into antiretroviral therapy (ART) adherence issues among transgender women. This study examined rates of self-reported ART adherence among transgender women on ART (n = 35) and well-established correlates of nonadherence, including depression, adherence self-efficacy, patient perceptions of interactions with their providers, and perceived adverse side effects of ART compared to other respondents (n = 2,770). Transgender women on ART were less likely to report 90% adherence rates or higher and reported less confidence in their abilities to integrate treatment regimens into their daily lives. When transgender women were compared to other respondents, regardless of the current medication regimen, they reported significantly fewer positive interactions with their health care providers. Training for providers and integration of hormone therapy into HIV care is recommended.

AB - Despite disproportionate rates of HIV among transgender women and evidence that medication adherence is necessary for treatment success and increased likelihood of survival, there has been little investigation into antiretroviral therapy (ART) adherence issues among transgender women. This study examined rates of self-reported ART adherence among transgender women on ART (n = 35) and well-established correlates of nonadherence, including depression, adherence self-efficacy, patient perceptions of interactions with their providers, and perceived adverse side effects of ART compared to other respondents (n = 2,770). Transgender women on ART were less likely to report 90% adherence rates or higher and reported less confidence in their abilities to integrate treatment regimens into their daily lives. When transgender women were compared to other respondents, regardless of the current medication regimen, they reported significantly fewer positive interactions with their health care providers. Training for providers and integration of hormone therapy into HIV care is recommended.

KW - adherence

KW - AIDS

KW - antiretroviral therapy

KW - HIV

KW - transgender

KW - women

UR - http://www.scopus.com/inward/record.url?scp=77950943172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950943172&partnerID=8YFLogxK

U2 - 10.1016/j.jana.2010.01.005

DO - 10.1016/j.jana.2010.01.005

M3 - Article

C2 - 20347342

AN - SCOPUS:77950943172

VL - 21

SP - 256

EP - 264

JO - Journal of the Association of Nurses in AIDS Care

JF - Journal of the Association of Nurses in AIDS Care

SN - 1055-3290

IS - 3

ER -